Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Mar 27, 2023; 15(3): 398-407
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.398
Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.398
Table 1 Distribution of patients based on treatment options, n (%)
| Surgical treatment | Interventional radiologic treatment | ||
| Complete surgical excision and antihelmintic therapy | 60 (48) | Percutaneous cyst drainage | 32 (25.6) |
| Partial resection and antihelmintic therapy | 23 (18.4) | Percutaneous cyst drainage with percutaneous biliary drainage | 2 (1.6) |
| Liver transplantation | 4 (3.2%) | Percutaneous biliary drainage only | 4 (3.2) |
| Total | 87 (69.6) | Total | 38 (30.4) |
Table 2 Details of the included patients
| No. | Age/gender | Location of cyst | Cystic content | Percutaneous treatment | Surgery |
| 1 | 35/M | RL | Infected | PD | LT |
| 2 | 47/F | LL | Non-infected | PD | No |
| 3 | 58/F | RL | Non-infected | PD-PBD | No |
| 4 | 60/F | LL | Non-infected | PD | No |
| 5 | 37/M | RL | Non-infected | PD | Right lobectomy |
| 6 | 66/F | RL | Non-infected | PD | No |
| 7 | 33/F | RL | Non-infected | PD | LT |
| 8 | 36/F | RL | Non-infected | PD | LT |
| 9 | 36/M | RL | Non-infected | PD | LT |
| 10 | 52/F | RL | Infected | PD-PBD | LT |
| 11 | 57/M | RL | Non-infected | PD | LT |
| 12 | 33/F | RL | Infected | PD | Right lobectomy |
| 13 | 26/F | RL | Infected | PD | Right lobectomy |
| 14 | 62/M | RL | Non-infected | PD | No |
| 15 | 39/M | LL | Infected | PD | No |
| 16 | 59/M | LL | Non-infected | PD | No |
| 17 | 66/F | LL | Non-infected | PD | No |
| 18 | 21/F | LL | Infected | PD | Left lobectomy |
| 19 | 24/M | RL | Non-infected | PD | LT |
| 20 | 35/M | RL | Non-infected | PD | LT |
| 21 | 51/M | RL | Non-infected | PD | Right lobectomy |
| 22 | 44/F | RL | Non-infected | PD | No |
| 23 | 28/M | RL | Infected | PD | LT |
| 24 | 57/F | RL | Non-infected | PD | LT |
| 25 | 71/F | RL | Non-infected | PD | No |
| 26 | 17/M | RL | Non-infected | PD | No |
| 27 | 39/F | RL | Non-infected | PD | No |
| 28 | 71/F | RL | Infected | PD | No |
| 29 | 50/F | RL | Infected | PD | Right lobectomy |
| 30 | 34/M | Bilateral | Non-infected | PD | No |
| 31 | 28/M | RL | Non-infected | PD | No |
| 32 | 50/M | LL | Non-infected | PD | Left lobectomy |
| 33 | 15/M | LL | Infected | PD | Inoperable |
| 34 | 61/M | RL | Infected | PD | Inoperable |
| 35 | 45/F | LL | Non-infected | PBD | No |
| 36 | 53/F | RL | Non-infected | PBD | LT |
| 37 | 25/F | RL | Non-infected | PBD | LT |
| 38 | 43/F | RL | Non-infected | PBD | LT |
- Citation: Eren S, Aydın S, Kantarci M, Kızılgöz V, Levent A, Şenbil DC, Akhan O. Percutaneous management in hepatic alveolar echinococcosis: A sum of single center experiences and a brief overview of the literature. World J Gastrointest Surg 2023; 15(3): 398-407
- URL: https://www.wjgnet.com/1948-9366/full/v15/i3/398.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i3.398
